Patent attorney Jay Halt explains how medtech companies should align IP strategy with FDA compliance to avoid unenforceable patents and regulatory issues.

RAS AL KHAIMAH, 23rd July, 2026 (WAM) -- The Ras Al Khaimah Department of Economic Development (RAK DED), represented by its Commercial Control and Protection Department, received 545 consumer ...

Introduction Africa stands at a pivotal moment in its economic evolution. Despite its vast natural endowments, youthful ...

Traditional motifs in the public domain belong to humanity's shared artistic heritage and can reasonably be used freely, ...

Congress wants to prevent foreign adversaries from harassing American companies and stealing their intellectual property. Its ...